Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Metformin hydrochloride extended release - Sun Pharmaceuticals Industries

Next Previous
Drug Profile

Metformin hydrochloride extended release - Sun Pharmaceuticals Industries

Alternative Names: metformin hydrochloride extended-release oral suspension; Riomet ER; Riomet ER™ - Sun Pharmaceutical Industries

Latest Information Update: 12 Jan 2022

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Sun Pharmaceutical Industries
  • Class Antihypercalcaemics; Antihyperglycaemics; Biguanides; Eye disorder therapies; Small molecules
  • Mechanism of Action AMP activated protein kinase stimulants; Gluconeogenesis inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Type 2 diabetes mellitus

Most Recent Events

  • 23 Sep 2020 Sun Pharmaceutical Industries issues voluntary nationwide recall of metformin hydrochloride extended-release due to N-nitrosodimethylamine content above the acceptable daily intake limit
  • 12 Mar 2020 Chemical structure information added
  • 26 Feb 2020 Launched for Type 2 diabetes mellitus (In children, In adults) in USA (PO)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top